|
|
|
Originator Org.- |
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.- |
First Approval Date- |
[Translation] Clinical pharmacokinetics study of cefrazone sodium for injection in healthy subjects
研究在中国成年健康受试者中: 1. 通过测定单次静脉滴注不同剂量头孢拉宗钠后受试者血浆和尿液中药物的浓度变化,估算单次给药的药代动力学参数; 2. 通过测定多次静脉滴注头孢拉宗钠后受试者血浆和尿液中药物的浓度变化,估算多次给药的药代动力学参数; 次要目的: 评价中国成年健康受试者接受不同剂量头孢拉宗钠的安全性
[Translation] To study in Chinese adult healthy subjects: 1. To estimate the pharmacokinetic parameters of a single dose by measuring the changes in plasma and urine concentrations of the drug in subjects after a single intravenous infusion of different doses of cefrazone sodium ; 2. To estimate the pharmacokinetic parameters of multiple doses by measuring the changes of drug concentration in plasma and urine of subjects after multiple intravenous infusions of cefrazone sodium; Secondary purpose: To evaluate Chinese adult healthy subjects The safety of patients receiving different doses of cefrazone sodium
100 Clinical Results associated with Chongqing Tiandi Pharmaceutical Co Ltd
0 Patents (Medical) associated with Chongqing Tiandi Pharmaceutical Co Ltd
100 Deals associated with Chongqing Tiandi Pharmaceutical Co Ltd
100 Translational Medicine associated with Chongqing Tiandi Pharmaceutical Co Ltd